Mouse monoclonal [4E3] Anti-Human IgG1 gamma chain (Biotin) (ab99775)
Key features and details
- Mouse monoclonal [4E3] Anti-Human IgG1 gamma chain (Biotin)
- Conjugation: Biotin
- Host species: Mouse
- Isotype: IgG1
- Suitable for: ELISA, ICC/IF
Related conjugates and formulations
製品の概要
-
製品名
Mouse monoclonal [4E3] Anti-Human IgG1 gamma chain (Biotin)
IgG1 二次抗体 製品一覧 -
由来種
Mouse -
ターゲット生物種
Human -
特異性
ab99775 reacts with the hinge region of the heavy chain of Human IgG1. May also react with IgG from other species. -
アプリケーション
適用あり: ELISA, ICC/IFmore details -
免疫原
Other Immunogen Type corresponding to IgG1.
-
標識
Biotin
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle. Store In the Dark. -
バッファー
pH: 7.4
Preservative: 0.1% Sodium azide
Constituent: PBS -
Concentration information loading...
-
精製度
Protein G purified -
ポリ/モノ
モノクローナル -
クローン名
4E3 -
アイソタイプ
IgG1 -
研究分野
関連製品
-
Alternative Versions
- Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (ab99771)
- Mouse monoclonal [4E3] anti- Human IgG1 - hinge heavy chain (FITC) (ab99772)
- Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (Alkaline Phosphatase) (ab99773)
- Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (HRP) (ab99774)
- Mouse monoclonal [4E3] Anti-Human IgG1 hinge heavy chain (PE) (ab99776)
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab99775の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ELISA |
1/1000 - 1/2000.
|
|
ICC/IF |
Use at an assay dependent dilution.
|
特記事項 |
---|
ELISA
1/1000 - 1/2000. |
ICC/IF
Use at an assay dependent dilution. |
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
SDS download
-
Datasheet download
参考文献 (7)
ab99775 は 7 報の論文で使用されています。
- Natama HM et al. Associations between prenatal malaria exposure, maternal antibodies at birth, and malaria susceptibility during the first year of life in Burkina Faso. Infect Immun 91:e0026823 (2023). PubMed: 37754682
- Alonso S et al. Reduced Placental Transfer of Antibodies Against a Wide Range of Microbial and Vaccine Antigens in HIV-Infected Women in Mozambique. Front Immunol 12:614246 (2021). PubMed: 33746958
- Alonso S et al. HIV infection and placental malaria reduce maternal transfer of multiple antimalarial antibodies in Mozambican women. J Infect 82:45-57 (2021). PubMed: 33636218
- Sanchez L et al. Antibody responses to the RTS,S/AS01E vaccine and Plasmodium falciparum antigens after a booster dose within the phase 3 trial in Mozambique. NPJ Vaccines 5:46 (2020). PubMed: 32550014
- Vidal M et al. Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens. J Immunol Methods N/A:N/A (2018). PubMed: 29397157
- Ubillos I et al. Optimization of incubation conditions of Plasmodium falciparum antibody multiplex assays to measure IgG, IgG1-4, IgM and IgE using standard and customized reference pools for sero-epidemiological and vaccine studies. Malar J 17:219 (2018). PubMed: 29859096
- Whary MT et al. Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev 14:1464-9 (2005). ELISA ; Human . PubMed: 15941957